Marom, IL
Anat Marom, Kiryat-Bialik IL
Patent application number | Description | Published |
---|---|---|
20130171116 | OPTICALLY SENSITIVE CELL NETWORK - A neural network is disclosed. The neural network comprises a plurality of optogenetically modified neural cells being three-dimensionally distributed in a hydrogel medium and being disconnected from any solid support having a shear modulus above 1 GPa. | 07-04-2013 |
20150031070 | OPTICALLY SENSITIVE CELL NETWORK - A neural network is disclosed. The neural network comprises a plurality of optogenetically modified neural cells being three-dimensionally distributed in a hydrogel medium and being disconnected from any solid support having a shear modulus above 1 GPa. | 01-29-2015 |
Daniel Marom, Petah Tikva IL
Patent application number | Description | Published |
---|---|---|
20130114915 | Foldable Bag - A foldable bag for insulating a bottle or other beverage container comprises means for attaching the bag in its folded state wherein the bag can serve as a label on the outside of the bottle, and means for attaching the bag to the bottle in its unfolded state wherein the bag envelops the bottle to provide thermal insulation. A method for attaching a folded label to a bottle comprises: attaching a first side of the label to the bottle using a glue; wrapping the label around the bottle; attaching a second side of the label to the surface of the label using glue, in such a way that the label becomes attached to the bottle and the second side covers the side opening at the first side of the label. | 05-09-2013 |
Daniel Marom, Kiryat Byalik IL
Patent application number | Description | Published |
---|---|---|
20120272249 | Data Processing Environment Event Correlation - A system and method for correlating events in data processing resources processing a workload. An event correlation service comprising an event correlation service software framework is provided on a processor unit. The event correlation service is configured, using the event correlation service software framework, for correlating the events from monitored data for the workload, wherein the workload is processed using the data processing resources provided by a provider of the data processing resources. The event correlation service receives monitored data for the workload as the workload is being processed. The monitored data is processed by the event correlation service to identify an occurrence of an event of interest for the workload as the workload is being processed. An output is provided in response to identifying the occurrence of the event of interest. | 10-25-2012 |
Dan M. Marom, Tel-Aviv IL
Patent application number | Description | Published |
---|---|---|
20120219252 | METHOD AND SYSTEM FOR SWITCHING OPTICAL CHANNELS - An optical switching system is disclosed. The system comprises: input optics, for receiving light from at least one input optical port and separating the light into a plurality of optical channels to assign a separate optical path to each channel of each input optical port. The system further comprises an input steering array and an output steering array arranged such that the input steering array is imaged onto the output steering array, wherein the input steering array is configured to receive the separated light and steer each optical channel to an individual element of the output steering array. The system further comprises output optics, for receiving the optical channels from the output steering array and coupling the optical channels into at least one output optical port. | 08-30-2012 |
Dan M. Marom, Mevaseret Zion IL
Patent application number | Description | Published |
---|---|---|
20130216228 | OPTICAL NETWORK UNIT, OPTICAL ACCESS NETWORK AND A METHOD FOR EXCHANGING INFORMATION - An Optical Access Network, a Optical Network Unit (ONU) and various methods for exchanging information are provided. The method may include: receiving, by the ONU, a pilot signal and downstream information signals; wherein the pilot signal is received at a pilot frequency slot and the downstream information signals are received at a downstream information frequency slot; wherein the ONU is allocated with a spectral slice that comprises the pilot frequency slot, the downstream information frequency slot, a guard frequency slot and an upstream information frequency slot; wherein at least one other spectral slice is allocated for exchanging information with at least one other group of ONUs; splitting the downstream information signals to downstream information signals portions; splitting the pilot signals to pilot signals portions; detecting downstream information, in response to at least a first portion of downstream information signals; modulating a portion of the pilot signal by upstream information signals to provide upstream information signals that are within the upstream information frequency slot; modulating a second portion of the downstream information signals by the upstream information signals to provide upstream secondary signals that are outside the pilot frequency slot, the downstream information frequency slot and the upstream information frequency slot; and upstream transmitting the upstream information signals and the upstream secondary signals. | 08-22-2013 |
Dan Mark Marom, Mevaseret Zion IL
Patent application number | Description | Published |
---|---|---|
20130315598 | SYSTEM AND METHOD FOR USE IN WAVELENGTH DIVISION MULTIPLEXER - A system and method are presented for use in dense wavelength division multiplexing. According to this technique, K spatially separated broadband optical beams are produced comprising respective K arrays of spectral components arranged with certain common periodicity, P, where the spectral components present data channels and are arranged in interleaved fashion in the K arrays, with spectral components of one array being shifted with respect to the next array a value substantially equal to said periodicity divided by number of separated broadband beams, or P(K−1)/K. Spectral shaping is applied to the K arrays to convert modulated-shape of the spectral components in the K arrays to K groups of desired spectral shape of data channels. This enables to combine the K groups of the spectral channels into a combined beam comprising all the spectral channels being arranged with substantially no gap between the channels. | 11-28-2013 |
20130328706 | SYSTEM AND METHOD FOR PHOTONICALLY ASSISTED ANALOG TO DIGITAL SIGNAL CONVERSION - A photonically assisted analog to digital conversion (ADC) system is presented. The system comprises: an optical sampling signal generator configured and operable for generating an optical sampling signal comprising a predetermined sampling pulse sequence in the form of a time separated pulse train of spectral components dispersed in a periodic fashion, where each pulse is distinguishable by a central wavelength thereof different from its neighboring pulses. The generation of the pulse sampling sequence is achieved by combining broadband dispersion and compensation with a periodic dispersion compensator having a free spectral range smaller than the broad bandwidth of the ultrashort pulse. The second innovative element is the introduction of coherent detection with oversampling of the interference terms of the phase modulated pulse sampling sequence and a reference pulse. The over-sampling provides additional measurements of the beat term and by way of error minimization a more reliable phase estimation is provided, translated into a more accurate conversion to digital representation. The system further comprises an electro-optical modulator for interacting an input electric analog signal and an optical sampling signal and generating a modulated optical signal indicative of said input signal; and a detection system configured and operable for receiving said modulated optical signal and generating an output digital signal corresponding to said input electric analog signal. | 12-12-2013 |
20150098697 | SYSTEM AND METHOD FOR MODE DIVISION MULTIPLEXING - A system and method are provided for coupling a plurality of optical signals, such as data signals, between a corresponding plurality of single mode optical fibers (SMFs) and a multi-mode optical fiber (MMF), by optically coupling the optical signals of the SMFs with respective spaced-apart regions at a facet of the MMF, such that at least some of the regions partially overlap with a plurality of different spatial modes supported by the MMF. The optical coupling is performed by utilizing imaging and beam shaping optics configured to couple each of the SMF optical signals and the respective region at the MMF's optical pupil by carrying out the following: (i) imaging the SMF optical signal propagating in between the associated SMF and the respective region of the MMF to focus the optical signal emanating from the SMF onto the respective region or vice versa; and (ii) shaping the optical signal being focused to convert a lateral field distribution thereof, between a first predetermined field distribution corresponding to the SMF's spatial mode and a second predetermined field distribution at the respective region. | 04-09-2015 |
Ehud Marom, Kfar Saba IL
Patent application number | Description | Published |
---|---|---|
20120015891 | DEPOT SYSTEMS COMPRISING GLATIRAMER OR A PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF - The present invention provides long acting parenteral pharmaceutical compositions comprising a therapeutically effective amount of glatiramer. In particular, the present invention provides a long acting pharmaceutical composition comprising a therapeutically effective amount of glatiramer acetate in depot form suitable for administering at a medically acceptable location in a subject in need thereof. The depot form is suitable for subcutaneous or intramuscular implantation or injection. | 01-19-2012 |
20120029000 | PROCESS FOR THE PREPARATION OF ALOGLIPTIN - The present invention is based on the discovery of a process for preparing pyrimidin-dione compounds, especially alogliptin and its derivatives, which comprises the reaction of a urea derivative of formula (VIII) with a malonic acid or its derivatives to form intermediates of formulae (VII) or (VII-A), which are subsequently converted to a compound of formula (II) upon introduction of a leaving group X. Compound (II) then reacts with an amine to form compound (I), which is optionally converted to its salts of formula (IV). | 02-02-2012 |
20120035142 | POLYMORPHS OF DARUNAVIR - The present invention provides new pseudopolymorphic forms of darunavir as well as a novel amorphous form of darunavir, pharmaceutical compositions comprising these compounds, methods for their preparation and use thereof in treating retroviral infections, in particular, HIV infection. | 02-09-2012 |
20120164229 | DEPOT SYSTEMS COMPRISING GLATIRAMER OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF - The present invention provides long acting parenteral pharmaceutical compositions comprising a therapeutically effective amount of glatiramer. In particular, the present invention provides a long acting pharmaceutical composition comprising a therapeutically effective amount of glatiramer acetate in depot form suitable for administering at a medically acceptable location in a subject in need thereof. The depot form is suitable for subcutaneous or intramuscular implantation or injection. | 06-28-2012 |
20120245361 | PROCESSES FOR THE PREPARATION OF DEFERASIROX, AND DEFERASIROX POLYMORPHS - The present invention relates to processes for the preparation of deferasirox, an oral iron chelator developed to treat iron overload due to e.g. multiple blood transfusions. The present invention further provides novel deferasirox pseudopolymorphs and a novel amorphous form of deferasirox, processes for their preparation, as well as pharmaceutical compositions comprising same, and use thereof in treating iron overload. | 09-27-2012 |
20120283463 | INTERMEDIATE COMPOUNDS AND PROCESSES FOR THE PREPARATION OF TAPENTADOL AND RELATED COMPOUNDS - The present invention discloses processes for the preparation of 3-[(1R,2R)-3-(dimethyl-amino)-1-ethyl-2-methyl-propyl]phenol (Tapentadol), salts thereof and related compounds of formula (A), including stereoisomers and pharmaceutically acceptable salts thereof, and to certain intermediates used in such process. | 11-08-2012 |
20120296101 | PROCESS FOR THE PREPARATION OF DARUNAVIR AND DARUNAVIR INTERMEDIATES - The present invention relates to a process for the preparation of darunavir, a nonpeptide protease inhibitor (PI), useful for the treatment of HIV/AIDS patients harboring multidrug-resistant HIV-1 variants that do not respond to previously existing HAART regimens. The present invention further relates to processes for the stereo-directed preparation of darunavir intermediates, in particular (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol and to certain novel intermediates obtained by such processes. | 11-22-2012 |
20130023570 | POLYMORPHS OF DARUNAVIR - The present invention provides new pseudopolymorphic forms of darunavir as well as a novel amorphous form of darunavir, pharmaceutical compositions comprising these compounds, methods for their preparation and use thereof in treating retroviral infections, in particular, HIV infection. | 01-24-2013 |
20130046103 | PREPARATION OF BENZOFURANS AND USE THEREOF AS SYNTHETIC INTERMEDIATES - The present invention provides several synthetic methods for preparing N-(2-butylbenzofuran-5-yl)-N-(methylsulfonyl)methanesulfonamide, a compound of formula (3), an intermediate in the preparation of Dronedarone. The present invention further provides a process for preparing Dronedarone, comprising the steps of converting 2-butyl-5-bis(methanesulfon)-amidobenzofuran of formula (3) to Dronedarone, wherein the 2-butyl-5-bis(methanesulfon)-amidobenzofuran of formula (3) is prepared by the processes of the present invention. | 02-21-2013 |
20130059872 | POLYMORPHS OF ALOGLIPTIN BENZOATE - The present invention provides new amorphous forms of alogliptin benzoate, pharmaceutical compositions comprising same, methods for their preparation and use thereof in treating conditions mediated by DPP-IV, in particular, type 2 diabetes. | 03-07-2013 |
20130156725 | RANDOM PENTAPOLYMER FOR TREATMENT OF AUTOIMMUNE DISEASES - The present invention relates to a synthetic polypeptide which is a random linear pentapolymer comprising alanine, glutamic acid, lysine, tyrosine and phenylalanine and use thereof in treating autoimmune diseases, in particular multiple sclerosis. | 06-20-2013 |
20130217899 | INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF FINGOLIMOD - The present invention relates to processes for the preparation of (2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride (Fingolimod) and pharmaceutically acceptable salts thereof, and intermediates formed in such processes. | 08-22-2013 |
20130225830 | POLYMORPHS OF FEBUXOSTAT - The present invention provides new crystalline forms of febuxostat, pharmaceutical compositions comprising same, methods for their preparation and use thereof in treating hyperuricaemia. | 08-29-2013 |
20130245065 | INTERMEDIATE COMPOUNDS AND PROCESSES FOR THE PREPARATION OF QUINOLINE DERIVATIVES SUCH AS LAQUINIMOD SODIUM - The present invention relates to processes for the preparation of quinoline-3-carboxamide derivatives, such as sodium 5-chloro-3-(ethylphenylcarbamoyl)-1-methyl-2-oxo-1,2-dihydroquinolin-4-olate (Laquinimod sodium). The present invention further relates to intermediates formed in such processes. | 09-19-2013 |
20140155363 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF ABIRATERONE ACETATE - The present invention relates to a process for the synthesis of (3beta)17-(3-pyridinyl)androsta-5,16-dien-3-yl acetate (Abiraterone acetate) represented by the structure of formula (1), and salts thereof, especially salts with pharmaceutically acceptable acids. The present invention further relates to certain intermediates in such processes. | 06-05-2014 |
20140179922 | INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF LURASIDONE AND SALTS THEREOF - The present invention relates to a process for the preparation of Lurasidone or a pharmaceutically acceptable salt thereof, a compound useful for the treatment of schizophrenia and bipolar disorder. The present invention further relates to processes for the preparation of Lurasidone intermediates, and to certain novel intermediates obtained by such processes. | 06-26-2014 |
20140304012 | INSURANCE POLICIES FOR STEM CELLS DEPOSITORS AND METHODS FOR PROVIDING SAME - A method, apparatus and computer program product for generating and applying insurance policies intended to guarantee sufficient amounts of available, viable stem cells to policy holders in case the policy holders are in need of stem cell therapy. An individual may deposit stem cells and give consent to allocate at least some of the stem cells deposited by said individual for public use, and in return be entitled to receive viable stem cells deposited by another individual in case of need. | 10-09-2014 |
20140343010 | CO-CRYSTALS OF DAPAGLIFLOZIN - The present invention provides novel co-crystal forms of dapagliflozin, namely a dapagliflozin lactose co-crystal and a dapagliflozin asparagine co-crystal, to pharmaceutical compositions comprising same, methods for their preparation and uses thereof for treating type 2 diabetes. | 11-20-2014 |
20140350004 | AMORPHOUS FORM OF DOLUTEGRAVIR - The present invention provides an amorphous form of dolutegravir sodium, pharmaceutical compositions comprising same, methods for its preparation and use thereof as an antiretroviral agent. | 11-27-2014 |
20140371273 | POLYMORPHS OF PERAMPANEL - The present invention provides novel crystalline forms of perampanel, pharmaceutical compositions comprising same, methods for their preparation and uses thereof for treating seizures and epilepsy. | 12-18-2014 |
20150051419 | INTERMEDIATE COMPOUNDS AND PROCESSES FOR THE PREPARATION OF QUINOLINE DERIVATIVES SUCH AS LAQUINIMOD SODIUM - The present invention relates to processes for the preparation of quinoline-3-carboxamide derivatives, such as sodium 5-chloro-3-(ethylphenylcarbamoyl)-1-methyl-2-oxo-1,2-dihydroquinolin-4-olate (Laquinimod sodium). The present invention further relates to intermediates formed in such processes. | 02-19-2015 |
20150148412 | POLYMORPHS OF DARUNAVIR - The present invention provides new pseudopolymorphic forms of darunavir as well as a novel amorphous form of darunavir, pharmaceutical compositions comprising these compounds, methods for their preparation and use thereof in treating retroviral infections, in particular, HIV infection. | 05-28-2015 |
Eli Marom, Givatayim IL
Patent application number | Description | Published |
---|---|---|
20120293355 | SYSTEM AND METHOD FOR DETECTING CONCEALED EXPLOSIVES AND WEAPONS - A method for detecting hidden explosives or weapons, including transmitting a signal in different polarization channels towards an object, the next stage includes collecting back scattered energy in different polarization channels from the object, the next stage includes determining parameters that are dependent upon the transmitted signal polarization channels and the backscattered energy polarization channels, and providing an indication if there are hidden explosives or weapons in the object based on the parameters. | 11-22-2012 |
Emanuel Marom, Tel Aviv IL
Patent application number | Description | Published |
---|---|---|
20100097487 | OPTICAL IMAGING SYSTEM WITH AN EXTENDED DEPTH-OF-FIELD AND METHOD FOR DESIGNING AN OPTICAL IMAGING SYSTEM - A method for designing a mask, the method includes: choosing or receiving a desired contrast value; and determining sizes, locations and shapes of multiple rotationally symmetric regions of a mask such as to define a modulation transfer function that is characterized by a substantially uniform response over a spatial frequency range; wherein the uniform response is substantially indifferent to an orientation of features of the object and to a location of the object within a deep depth-of-field region. An optical imaging system that includes: a mask that includes multiple rotationally regions; wherein the multiple rotationally symmetric regions are shaped and positioned such as to define a modulation transfer function that is characterized by a substantially uniform response over a spatial frequency range, wherein the uniform response is substantially indifferent to an orientation of features of the object and to a location of the object within a deep depth-of-field region. | 04-22-2010 |
20110197428 | OPTICAL MASK FOR ALL-OPTICAL EXTENDED DEPTH-OF-FIELD FOR IMAGING SYSTEMS UNDER INCOHERENT ILLUMINATION - A method of optical element manufacturing, the method may include selecting a range of a misfocus parameter ψ; and designing the optical element to comprise multiple regions, wherein the optical transfer function (OTF) of the optical element allows, for the range of the misfocus parameter ψ, transmission of images with a contrast of at least 10% for all normalized spatial frequencies up to 50% of a theoretical maximum that is attainable with a full aperture in an in-focus condition. | 08-18-2011 |
20110222763 | DEVICES AND METHODS OF READING MONOCHROMATIC PATTERNS - A method of extracting data from an identifiable monochromatic pattern. The method comprises separating a polychromatic optical signal, received from an object having identifiable monochromatic pattern, into a plurality of wavelength components, separately capturing each of the wavelength components, reconstructing a plurality of images each from a different wavelength component, detecting the identifiable monochromatic pattern in one or more of the images, and extracting data associated with or encoded by the detected identifiable monochromatic pattern. The images have different depths of field. | 09-15-2011 |
20140131447 | DEVICES AND METHODS OF READING MONOCHROMATIC PATTERNS - A method of extracting data from an identifiable monochromatic pattern. The method comprises separating a polychromatic optical signal, received from an object having identifiable monochromatic pattern, into a plurality of wavelength components, separately capturing each of the wavelength components, reconstructing a plurality of images each from a different wavelength component, detecting the identifiable monochromatic pattern in one or more of the images, and extracting data associated with or encoded by the detected identifiable monochromatic pattern. The images have different depths of field. | 05-15-2014 |
Esti Esty Marom, Ramat Gan IL
Patent application number | Description | Published |
---|---|---|
20100076200 | Purification of olmesartan medoxomil - The present invention provides a process for purifying olmesartan medoxomil. | 03-25-2010 |
Gad Marom, Jerusalem IL
Patent application number | Description | Published |
---|---|---|
20090302226 | SOLID-STATE NEUTRON AND ALPHA PARTICLES DETECTOR AND METHODS FOR MANUFACTURING AND USE THEREOF - A solid-state detector for detection of neutron and alpha particles detector and methods for manufacturing and use thereof are described. The detector has an active region formed of a polycrystalline semiconductor compound comprising a particulate semiconductor material sensitive to neutron and alpha particles radiation imbedded in a binder. The particulate semiconductor material contains at least one element sensitive to neutron and alpha particles radiation, selected from a group including 10Boron, 6Lithium, 113Cadmium, 157Gadolinium and 199Mercury. The semiconductor compound is sandwiched between an electrode assembly configured to detect the neutron and alpha particles interacting with the bulk of the active region. The binder can be either an organic polymer binder or inorganic binder. The organic polymer binder comprises at least one polymer that can be selected from the group comprising polystyrene, polypropylene, Humiseal™ and Nylon-6. The inorganic binder can be selected from B2O3, PbO/B2O3/, Bi2O3/PbO, Borax glass, Bismuth Borate glass and Boron Oxide based glass. | 12-10-2009 |
20100297724 | METAL ENTRAPPED COMPOUNDS - The present invention provides a composite comprising at least one hydrophobic organic compound and a matrix of at least one metal; wherein said at least one hydrophobic compound is entrapped within said matrix, compositions comprising at least one composite and methods of its preparation. | 11-25-2010 |
20140374663 | METALS DOPED WITH ORGANIC MATERIAL - A metallic composite is disclosed including a corrodible metal and an organic material which endows the composite with resistance to corrosion. | 12-25-2014 |
Itamar Marom, Bet Dagan IL
Patent application number | Description | Published |
---|---|---|
20110285194 | VEHICLE HEADREST ASSEMBLY - A headrest assembly in combination with a vehicle seat ( | 11-24-2011 |
Karen Marom, Mevaseret Zion IL
Patent application number | Description | Published |
---|---|---|
20100105627 | PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY - The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid and a hydrophobic medium, e.g. castor oil or glyceryl tricaprylate or a mixture thereof. The pharmaceutical compositions described herein contain medium chain fatty acid salts and are substantially free of alcohols. The pharmaceutical compositions may be encapsulated in a capsule. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed. | 04-29-2010 |
20110257095 | PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY - The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid and a hydrophobic medium, e.g. castor oil or glyceryl tricaprylate or a mixture thereof. The pharmaceutical compositions described herein contain medium chain fatty acid salts and are substantially free of alcohols. The pharmaceutical compositions may be encapsulated in a capsule. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed. | 10-20-2011 |
20120009229 | PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY - The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid and a hydrophobic medium, e.g. castor oil or glyceryl tricaprylate or a mixture thereof. The pharmaceutical compositions described herein contain medium chain fatty acid salts and are substantially free of alcohols. The pharmaceutical compositions may be encapsulated in a capsule. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed. | 01-12-2012 |
20120093886 | PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY - The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid and a hydrophobic medium, e.g. castor oil or glyceryl tricaprylate or a mixture thereof. The pharmaceutical compositions described herein contain medium chain fatty acid salts and are substantially free of alcohols. The pharmaceutical compositions may be encapsulated in a capsule. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed. | 04-19-2012 |
20150031631 | PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY - The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid and a hydrophobic medium, e.g. castor oil or glyceryl tricaprylate or a mixture thereof. The pharmaceutical compositions described herein contain medium chain fatty acid salts and are substantially free of alcohols. The pharmaceutical compositions may be encapsulated in a capsule. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed. | 01-29-2015 |
Karen Marom, Mevasseret Zion IL
Patent application number | Description | Published |
---|---|---|
20110311621 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF DELVERY - The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent (such as CCK-8, octreotide), at least one salt of a medium chain fatty acid, a matrix forming polymer and a hydrophobic(lipophilic) medium. A surfactant may be included in the suspension. The pharmaceutical compositions may be formulated in a capsule or tablet for oral delivery. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed. | 12-22-2011 |
Moshe Marom, Herzlia IL
Patent application number | Description | Published |
---|---|---|
20100310989 | METHOD OF PROVIDING LITHOGRAPHIC PRINTING PLATES - Lithographic printing plates can be obtained by contacting infrared radiation-imaged negative-working lithographic printing plate precursors with a processing solution having a pH less than 9 and comprising a UV photoinitiator. After this processing, the lithographic printing plate is floodwise exposed with UV radiation. Providing a UV-photoinitiator in the processing solution followed by UV exposure can increase imaging sensitivity and printing plate run-length, and reduce print background. | 12-09-2010 |
20120045720 | DEVELOPERS AND METHOD OF COLORING LITHOGRAPHIC PRINTING MEMBERS - A color contrast image in imaged lithographic printing precursors can be obtained by contacting the imaged precursor with a coloration solution containing a colorless form of a photochromic compound. Residual amounts of this compound attached to the oleophilic surface of the imaged precursor can be changed to its colored form when exposed to UV light. The coloration solution can be an alkaline or acidic developer or an alkaline or acidic solution used separately after development. The coloration solution can also be a gum solution. | 02-23-2012 |
20120219915 | PREPARATION OF LITHOGRAPHIC PRINTING PLATES - Negative-Working Lithographic Printing Plate Precursors can be provided with desired contrast coloration after imaging using a coloring fluid that includes a water-insoluble colorant that is soluble in a water-insoluble fatty alcohol. The coloring fluid provides an optical density change in the exposed regions of at least OD | 08-30-2012 |
Moshe Marom, Kfar Saba IL
Patent application number | Description | Published |
---|---|---|
20090241791 | PLATE TRANSPORT SPEED CONTROL SYSTEM - An apparatus for preventing printing plate deformation ( | 10-01-2009 |
20090244643 | SYSTEM FOR PLATE IMAGING AND PROCESSING - A system for enhanced plate processing including an imaging device ( | 10-01-2009 |
20100209098 | DEVELOPER WASTE REUSE - An apparatus for reusing developer liquid in a plate processor device includes: a new developer liquid container ( | 08-19-2010 |
20100224257 | REDUCING FOAM FORMATION - An apparatus for reducing foam formation of a developer liquid ( | 09-09-2010 |
20110016969 | DEVELOPER LIQUID LEVEL SENSOR - An apparatus for detecting developer liquid ( | 01-27-2011 |
20110091200 | PLATE DEVELOPER WITH A CONFIGURABLE TRANSPORT PATH - A development device ( | 04-21-2011 |
20110132217 | MINIMIZE CARBONIZATION OF DEVELOPER LIQUID - An apparatus designed to minimize carbonization of developer liquid within a printing plate developer device ( | 06-09-2011 |
Nir Marom, Tzur-Moshe IL
Patent application number | Description | Published |
---|---|---|
20150120072 | SYSTEM AND METHOD FOR ON-DEMAND ELECTRICAL POWER - A system and method for system for providing on-demand renewable energy are provided. The system comprises at least one power unit for converting environmental energy into electrical power, wherein the electrical power is drawn from the at least one power unit; and a regulator for controlling an amount of the electrical power drawn from the at least one power unit based on an authorization rule, wherein the authorization rule is checked upon each attempt to draw the electrical power from the at least one power unit. | 04-30-2015 |
20150241898 | SECURED ON-DEMAND ENERGY SYSTEMS - A system for providing electrical energy to an energy consumer includes an environmental energy source; an energy storage unit being electrically connected to the environmental energy source and configured to operate with the environmental energy source; and a control unit connected to the environmental energy source and to the energy storage unit, the control unit further comprising an authentication unit configured to periodically authenticate operation of the energy storage unit with the environmental energy source such that, upon authentication by the authentication unit, the control unit enables energy to flow from the environmental energy source to the energy storage unit. | 08-27-2015 |
Ophir Marom, Zichron Yaacov IL
Patent application number | Description | Published |
---|---|---|
20130236981 | Detection Of Chronic Kidney Disease And Disease Progression - The present invention provides a sensor or a system comprising gold nanoparticles coated with specific organic coatings for diagnosing, staging or monitoring chronic kidney disease. | 09-12-2013 |
Rafi Marom, Haifa IL
Patent application number | Description | Published |
---|---|---|
20090327663 | Power Aware Retirement - In one embodiment, the present invention includes a retirement unit to receive and retire executed instructions. The retirement unit may include a first array to receive information at allocation and a second array to receive information after execution. The retirement unit may further include logic to calculate an event associated with an executed instruction if information associated with the executed instruction is stored in an on-demand portion of at least one of arrays. Other embodiments are described and claimed. | 12-31-2009 |
Ron Marom, Givataim IL
Patent application number | Description | Published |
---|---|---|
20140129273 | System and Method for Visual Role Engineering - The system and method of visual role engineering uses a visual assessment tool to identify clusters of users and to define roles. A “cluster image” is generated that visually depicts the cluster tendencies of users and permissions. An operator of the visual assessment tool can visually identify clusters of users with the same permissions. The operator may select a cluster representing a subset of users, define a role for the subset of users, and assign permissions to the role. The process may be repeated in an iterative fashion until it is determined that no more roles are needed. | 05-08-2014 |
Shimon Marom, Haifa IL
Patent application number | Description | Published |
---|---|---|
20090257990 | Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues - Polynucleotide expression constructs, populations of cells and methods of treating diseases caused by dysfunction in, or damage to, excitable tissues are provided. | 10-15-2009 |
20100015105 | METHOD OF TREATING SCHIZOPHRENIA - A method of treating schizophrenia in a subject in need thereof is provided. The method comprising, administering to the subject a therapeutically effective amount of cells expressing at least one exogenous polypeptide forming a connexin channel and/or a hyperpolarizing ion channel, thereby treating the schizophrenia in the subject. | 01-21-2010 |
20100297083 | Polynucleotides and Polypeptide of Human KV1.3, Compositions Comprising Same and Methods of Using Same - An isolated polypeptide comprising, contiguously, a first amino acid sequence being at least 90% homologous to amino acid coordinates 1-398 of SEQ ID NO: 2, a tryptophan residue and a second amino acid sequence being at least 90% homologous to amino acid coordinates 400-523 of SEQ ID NO: 2. Also provided are polynucleotide sequences encoding this polypeptide and uses of same in the treatment of medical conditions associated with ion channel insufficiency. | 11-25-2010 |
Shlomy Marom, Holon IL
Patent application number | Description | Published |
---|---|---|
20160006765 | CONNECTION-SPECIFIC COMMUNICATION MANAGEMENT - A method of managing a connection-specific policy for accessing a target system includes receiving a request from a user client for a connection with a target system. A unique identifier is determined for the requested connection. Connection settings for connecting to the target system are provided to the user client. The connection settings include the unique connection identifier. A corresponding access policy for the connection identifier is provided to the target system. The target system applies the corresponding access policy on the connection established with the connection settings. | 01-07-2016 |
Shy Marom, Ramat Hasharon IL
Patent application number | Description | Published |
---|---|---|
20120136697 | METHOD AND SYSTEM FOR EFFICIENT DEPLOYMENT OF WEB APPLICATIONS IN A MULTI-DATACENTER SYSTEM - A system for computing an optimal deployment of at least one web application in a multi-datacenter system comprising a collector for collecting performance measurements with regard to a web application executed in the multi-datacenter system and grouping the performance measurements according to locations of a plurality of clients accessing the web application; a data repository for maintaining at least a performance table including at least the performance measurements grouped according to the plurality of client locations and a service level agreement (SLA) guaranteed to clients in the plurality of client locations; and an analyzer for processing at least information stored in the performance table for generating a recommendation on an optimal deployment of the web application in at least one combination of datacenters in the multi-datacenter system by computing an expected SLA that can be guaranteed to the clients in each combination of datacenters. | 05-31-2012 |
20140068073 | METHOD AND SYSTEM FOR EFFICIENT DEPLOYMENT OF WEB APPLICATIONS IN A MULTI-DATACENTER SYSTEM - A system for computing an optimal deployment of at least one web application in a multi-datacenter system comprising a collector for collecting performance measurements with regard to a web application executed in the multi-datacenter system and grouping the performance measurements according to locations of a plurality of clients accessing the web application; a data repository for maintaining at least a performance table including at least the performance measurements grouped according to the plurality of client locations and a service level agreement (SLA) guaranteed to clients in the plurality of client locations; and an analyzer for processing at least information stored in the performance table for generating a recommendation on an optimal deployment of the web application in at least one combination of datacenters in the multi-datacenter system by computing an expected SLA that can be guaranteed to the clients in each combination of datacenters. | 03-06-2014 |
Tal Marom, Rishon Lezion IL
Patent application number | Description | Published |
---|---|---|
20120029355 | Bone Sonometer - A probe device is for performing a bone density measurement is disclosed. The device comprises at least one ultrasound source for providing ultrasonic pulses; a plurality of ultrasound detectors for measuring the differences in arrival times of said ultrasonic pulses; at least one dedicated data processing element adapted for determining differences in arrival times of ultrasonic pulses; means for transferring data from said at least one measurement transducer to said at least one dedicated data processing element; and communication means adapted to transmit data from said dedicated data processing element to a non-dedicated computing means. Unlike systems known in the art, the measurements of the times of arrival of the ultrasonic pulses are performed within the probe itself, obviating the need for a dedicated computer system or measurement card. | 02-02-2012 |